相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pembrolizumab versus chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: The phase 3 KEYNOTE-177 Study
Kai-Keen Shiu et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer
Julien Taieb et al.
DRUGS (2019)
The Role of Local Treatment in Oligometastatic and Oligoprogressive Cancer
Jan Haussmann et al.
DEUTSCHES ARZTEBLATT INTERNATIONAL (2019)
Colorectal Cancer Biomarkers in the Era of Personalized Medicine
Jai N. Patel et al.
JOURNAL OF PERSONALIZED MEDICINE (2019)
Biomarkers in colorectal liver metastases
S. Yamashita et al.
BRITISH JOURNAL OF SURGERY (2018)
Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study
S. Stintzing et al.
EUROPEAN JOURNAL OF CANCER (2017)
Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group
D. P. Modest et al.
ANNALS OF ONCOLOGY (2016)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites
Wafik S. El-Deiry et al.
CANCER BIOLOGY & THERAPY (2015)
Cancer Stem Cell Markers Are Associated With Distant Hematogenous Liver Metastases But Not With Peritoneal Carcinomatosis in Colorectal Cancer
Jens Neumann et al.
CANCER INVESTIGATION (2015)
Expression of cancer stem cell markers in metastatic colorectal cancer correlates with liver metastasis, but not with metastasis to the central nervous system
Marlies Michl et al.
PATHOLOGY RESEARCH AND PRACTICE (2015)
Pattern of distant metastases in colorectal cancer: a SEER based study
Miaozhen Qiu et al.
ONCOTARGET (2015)
Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials
M. J. Sorich et al.
ANNALS OF ONCOLOGY (2015)
Association between KRAS mutation and lung metastasis in advanced colorectal cancer
A. A. L. Pereira et al.
BRITISH JOURNAL OF CANCER (2015)
RAS Mutations Affect Pattern of Metastatic Spread and Increase Propensity for Brain Metastasis in Colorectal Cancer
Rona Yaeger et al.
CANCER (2015)
Resection of Pulmonary Metastases from Colon and Rectal Cancer: Factors to Predict Survival Differ Regarding to the Origin of the Primary Tumor
G. Meimarakis et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Differential WNT Activity in Colorectal Cancer Confers Limited Tumorigenic Potential and Is Regulated by MAPK Signaling
David Horst et al.
CANCER RESEARCH (2012)
Survival Differences in Patients With Metastatic Colorectal Cancer and With Single Site Metastatic Disease at Initial Presentation: Results From South Australian Clinical Registry for Advanced Colorectal Cancer
Muhammad A. Khattak et al.
CLINICAL COLORECTAL CANCER (2012)
A simple immunohistochemical algorithm predicts the risk of distant metastases in right-sided colon cancer
Jens Neumann et al.
HISTOPATHOLOGY (2012)
Molecular Genetics of Colorectal Cancer
Eric R. Fearon
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer
Jeanne Tie et al.
CLINICAL CANCER RESEARCH (2011)
Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study
Emmanuel Mitry et al.
GUT (2010)
The Intratumoral Distribution of Nuclear β-Catenin Is a Prognostic Marker in Colon Cancer
David Horst et al.
CANCER (2009)
The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer
David Horst et al.
JOURNAL OF PATHOLOGY (2009)
KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis
Paloma Cejas et al.
PLOS ONE (2009)
CD133 expression is an independent prognostic marker for low survival in colorectal cancer
D. Horst et al.
BRITISH JOURNAL OF CANCER (2008)
Actual 10-year survival after resection of colorectal liver Metastases defines cure
James S. Tomlinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Surgical resection of pulmonary metastases from colorectal cancer: A systematic review of published series
Joachim Pfannschmidt et al.
ANNALS OF THORACIC SURGERY (2007)
APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression
Klaus-Peter Janssen et al.
GASTROENTEROLOGY (2006)
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer:: results of a multivariate analysis of 3825 patients
CH Köhne et al.
ANNALS OF ONCOLOGY (2002)
分享论文
